Owen Mumford launches TB test:
This article was originally published in Clinica
Executive Summary
Owen Mumford has launched Uniheaf, a single-use, multiple puncture TB test which removes any risk of hepatitis B, C and HIV transmission. The device has six needles that penetrate 0.6mm intradermally and administer the purified TB protein derivative. Uniheaf is available from the Oxford, UK-based company at £8.80 ($13.5) per carton of ten tests. The World Health Organisation reported 8.8 million new cases of TB in 1995 and estimates 30 million deaths from TB worldwide in the next decade.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.